| MA Credit Income Trust (MA1) ORDINARY UNITS FULLY PAID |
- |
$551 |
Monthly Estimate NTA for May 2025
|
12 Jun 2025 10:22AM |
$2.040 |
$1.970 |
fallen by
3.43%
|
|
| PTR Minerals Ltd (PTR) ORDINARY FULLY PAID |
Materials |
$39 |
EGM - CEO Presentation
|
12 Jun 2025 10:19AM |
$0.295 |
$0.099 |
fallen by
66.44%
|
|
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$8 |
Landmark Venture Forum Presentation
|
12 Jun 2025 10:14AM |
$0.011 |
$0.017 |
risen by
54.55%
|
|
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,848 |
Mesoblast Maintains Momentum with FDA
|
12 Jun 2025 10:14AM |
$1.820 |
$2.200 |
risen by
20.88%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$10 |
SHOCK DOCTOR MANUFACTURING AGREEMENT
|
12 Jun 2025 10:09AM |
$0.019 |
$0.013 |
fallen by
31.58%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- HitIQ Limited entered into a manufacturing agreement with Shock Doctor, a division of United Sports Brands.
- The agreement focuses on the manufacturing of smart mouthguard devices using HitIQ’s technology.
- Shock Doctor’s global manufacturing and distribution capabilities will be leveraged.
- The agreement is expected to enhance production scale, quality, and international market reach.
- HitIQ aims to access key international markets through Shock Doctor’s established infrastructure.
- The partnership is strategically significant for scaling HitIQ’s business operations.
- The agreement details manufacturing terms, distribution plans, and expected business benefits.
- Improved efficiencies and cost-effectiveness in manufacturing are anticipated.
- The agreement supports HitIQ’s mission to expand its presence in the sports technology sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wide Open Agriculture Ltd (WOA) ORDINARY FULLY PAID |
Consumer Staple |
$9 |
High Purity Lupin Oil Extracted from Initial Trials
|
12 Jun 2025 10:06AM |
$0.019 |
$0.014 |
fallen by
26.32%
|
|
| Trigg Minerals Limited (TMG) ORDINARY FULLY PAID |
Materials |
- |
Application for quotation of securities - TMG
|
12 Jun 2025 10:05AM |
$0.082 |
$0.120 |
risen by
46.34%
|
|
| NetLinkz Limited (NET) ORDINARY FULLY PAID |
Information Technology |
- |
Half Yearly Report and Accounts
|
12 Jun 2025 10:01AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| EV Resources Limited (EVR) ORDINARY FULLY PAID |
Materials |
$30 |
EVR Completes Acquisition of Los Lirios Antimony Mine
|
12 Jun 2025 9:59AM |
$0.006 |
$0.010 |
risen by
66.67%
|
|
EVR - Price-sensitive ASX Announcement
Full Release
Key Points
- EV Resources Limited completed the acquisition of the Los Lirios Antimony Mine in Sonora, Mexico.
- The acquisition supports EV Resources' strategy to focus on critical minerals, particularly antimony.
- Antimony is identified as a critical mineral for industrial, technological, and defense applications.
- The transaction structure and due diligence process have been completed.
- Ongoing operational plans for Los Lirios aim to enhance production and resource development.
- The acquisition is expected to strengthen the company’s supply chain for critical minerals.
- Global demand for antimony is rising, increasing the relevance of such resource assets.
- The Los Lirios mine acquisition complements EV Resources' existing asset portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Touch Ventures Limited (TVL) ORDINARY FULLY PAID |
Financials |
$41 |
Net Tangible Asset Backing - May 2025
|
12 Jun 2025 9:57AM |
$0.069 |
$0.058 |
fallen by
15.94%
|
|
| Commonwealth Bank of Australia (CBA) ORDINARY FULLY PAID |
Financials |
$289,576 |
Issue of AUD 1.5 Billion worth of Subordinated Securities
|
12 Jun 2025 9:54AM |
$181.400 |
$173.040 |
fallen by
4.61%
|
|
| Mayur Resources Limited (MRL) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
- |
Pause in Trading
|
12 Jun 2025 9:54AM |
$0.285 |
$0.300 |
risen by
5.26%
|
|
MRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Mayur Resources Limited requested a trading halt on its securities.
- The trading halt is pending an announcement about a capital raising.
- ASX granted the trading halt effective from the start of trading on 5 June 2024.
- The halt will last until the earlier of 7 June 2024 or the release of the announcement.
- The halt is to ensure the market is fully informed and to maintain an orderly market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$452 |
NAV 31 May 2025
|
12 Jun 2025 9:54AM |
$1.130 |
$1.695 |
risen by
50%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$109 |
Successful Phase 2 clinical trial of ISLA-101
|
12 Jun 2025 9:53AM |
$0.200 |
$0.370 |
risen by
85%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Island Pharmaceuticals Limited completed Phase 2 PEACH trial for ISLA-101.
- The study met key efficacy and safety endpoints for dengue fever prevention and treatment.
- ISLA-101 demonstrated a favorable safety profile in the tested population.
- Results support continued development and progression to later-stage clinical studies.
- The company is engaging with regulatory authorities for the advancement of ISLA-101.
- ISLA-101 offers a potential solution for mosquito-borne viral diseases, including dengue.
- Island Pharmaceuticals will explore partnerships and additional funding opportunities.
- There is a significant unmet need for dengue therapeutics globally.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$317 |
NTA at 06.06.25 Pre-tax 140.41 Post-tax 135.27
|
12 Jun 2025 9:52AM |
$1.200 |
$1.230 |
risen by
2.50%
|
|
| Saunders International Limited (SND) ORDINARY FULLY PAID |
Industrials |
$116 |
Final Director's Interest Notice
|
12 Jun 2025 9:52AM |
$0.765 |
$0.830 |
risen by
8.50%
|
|
| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$28 |
Dalaroo to Acquire Advanced Gold Project - Updated
|
12 Jun 2025 9:51AM |
$0.042 |
$0.085 |
risen by
102.38%
|
|
| Katana Capital Limited (KAT) ORDINARY FULLY PAID |
Financials |
$44 |
Update - Notification of buy-back - KAT
|
12 Jun 2025 9:49AM |
$1.210 |
$1.380 |
risen by
14.05%
|
|
| Macquarie Group Limited (MQG) ORDINARY FULLY PAID |
Financials |
$90,783 |
Dividend/Distribution - MQGPD
|
12 Jun 2025 9:49AM |
$217.060 |
$238.190 |
risen by
9.73%
|
|
| MPR Australia Limited (MPR) ORDINARY FULLY PAID |
Financials |
$2 |
MPOWER TO SELL RENEWABLE ENERGY PLATFORM
|
12 Jun 2025 9:48AM |
$0.008 |
$0.005 |
fallen by
37.50%
|
|
MPR - Price-sensitive ASX Announcement
Full Release
Key Points
- MPower Group Limited to sell its renewable energy platform to TagEnergy.
- The sale includes assets related to the development of renewable energy projects and a portfolio of Battery Energy Storage Systems (BESS).
- Transaction valued at AUD 20 million on a debt-free, cash-free basis.
- Proceeds from the sale will strengthen MPower's balance sheet.
- MPower will refocus efforts on its engineering, procurement, and construction (EPC) business.
- The transaction is subject to shareholder approval and customary conditions.
- MPower expects the sale to provide strategic and operational benefits.
- The deal is anticipated to position MPower for future growth in the energy sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| JPMorgan US 100Q Equity Premium Income Active ETF (Managed Fund) (Hedged) (JPHQ) |
Financials |
$12 |
Distribution Tax Estimates
|
12 Jun 2025 9:48AM |
$54.980 |
$61.040 |
risen by
11.02%
|
|
| EVE Health Group Limited (EVE) ORDINARY FULLY PAID |
Consumer Staple |
$10 |
EVE Completes Nextract Acquisition
|
12 Jun 2025 9:47AM |
$0.040 |
$0.029 |
fallen by
27.50%
|
|
EVE - Price-sensitive ASX Announcement
Full Release
Key Points
- EVE Health Group Limited has completed the acquisition of Nextract Pty Ltd.
- The acquisition will enhance EVE's capacity in plant extraction and health product formulation.
- EVE expects to broaden its product portfolio and enter new markets with Nextract's capabilities.
- Integration of Nextract is set to drive growth and open up new commercial opportunities for EVE.
- The acquisition aligns with EVE's strategic objectives to become a leading player in the health and wellness sector.
- Management anticipates synergies from the acquisition to benefit shareholders and customers.
- Completion of the acquisition was announced on 28 March 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clara Resources Australia Limited (C7A) ORDINARY FULLY PAID |
Materials |
$8 |
Trading Halt
|
12 Jun 2025 9:46AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
C7A - Price-sensitive ASX Announcement
Full Release
Key Points
- Clara Resources Australia Limited (ASX: C7A) requested a trading halt on 4 June 2024.
- The trading halt is due to a pending announcement related to a capital raising.
- The halt will remain until the announcement is made or trading resumes on 6 June 2024.
- The company is taking this action to ensure an orderly market and appropriate information dissemination.
- Previously, the company was known as Australian Pacific Coal Limited (ASX: AQC).
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AGL Energy Limited (AGL) ORDINARY FULLY PAID |
Utilities |
$6,519 |
Response to media speculation
|
12 Jun 2025 9:46AM |
$10.240 |
$9.690 |
fallen by
5.37%
|
|
AGL - Price-sensitive ASX Announcement
Full Release
Key Points
- AGL Energy Limited responds to media speculation about its operations.
- The company reviews all options to support its long-term strategy.
- No certainty that any specific transaction or option will be pursued.
- AGL is committed to continuous disclosure and will update the market as required.
- The response aims to clarify AGL’s position and obligations amid speculation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AnteoTech Limited (ADO) ORDINARY FULLY PAID |
Materials |
$33 |
AnteoBind Order Received and Life Sciences Update
|
12 Jun 2025 9:43AM |
$0.009 |
$0.011 |
risen by
22.22%
|
|
ADO - Price-sensitive ASX Announcement
Full Release
Key Points
- AnteoTech Limited received a notable order for AnteoBind from ADO.
- This order strengthens AnteoTech’s commercial relationship with ADO and validates its surface coating technology.
- AnteoBind is gaining traction in the life sciences sector, particularly in immunoassay development and diagnostics.
- The company is pursuing strategic partnerships and collaborations to increase adoption of AnteoBind.
- AnteoTech is focused on expanding its commercial pipeline and increasing its global presence in the life sciences market.
- Updates include advancing business development activities and targeting key market segments.
- The announcement highlights the importance of the ADO order as a potential catalyst for further market penetration.
- AnteoTech continues to invest in its proprietary technologies and build relationships with new and existing customers.
- The company remains committed to innovation and commercial growth in the life sciences sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
